DCOY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Decoy Therapeutics Inc (DCOY) is not a good buy at the moment for a beginner investor with a long-term strategy. The company has weak financial performance, no recent positive news or catalysts, and lacks strong trading signals or analyst support to justify immediate investment.
No trend data available. The stock closed at $0.7501 with a pre-market drop of -3.51% and a regular market increase of 3.32%.
NULL identified. No recent news or significant insider/hedge fund activity.
Weak financial performance in Q3 2025, with declining net income (-10.15% YoY) and EPS (-84.09% YoY). No recent congress trading data or significant trading trends.
In Q3 2025, revenue remained at $0 with no growth. Net income dropped to -$873,467 (-10.15% YoY), and EPS fell to -1.81 (-84.09% YoY). Gross margin remained at 0%.
Ladenburg initiated coverage on 2026-01-23 with a Buy rating and a price target of $2.50, but no other analyst updates or revisions are available.
